11,849
Views
33
CrossRef citations to date
0
Altmetric
Commentary

Acute pain: a multifaceted challenge – the role of nimesulide

, , , , , , , , , , , , , , , , & show all
Pages 23-36 | Accepted 11 Sep 2015, Published online: 15 Oct 2015

References

  • Sawdy R, Slater D, Fisk N, et al. Use of a cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery. Lancet 1997;350:265-6
  • Vane JR, Botting RM. Anti-inflammatory drugs and their mechanism of action. Inflamm Res 1998;47(Suppl 2):S78-87
  • Bessone F. Non-steroidal anti-inflammatory drugs: what is the actual risk of liver damage? World J Gastroenterol 2010;16:5651-61
  • European Medicines Agency. Assessment report for nimesulide containing medicinal products for systemic use. Procedure number: EMEA/H/A-31/1261. Referral under Article 31 of Directive 2001/83/EC, as amended
  • Castellsague J, Pisa F, Rosolen V, et al. Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti-inflammatory drugs in Friuli Venezia Giulia, Italy. Pharmacoepidemiol Drug Saf 2013;22:365-75
  • Castellsague J, Riera-Guardia N, Calingaert B, et al. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf 2012;35:1127-46
  • Gulmez SE, Larrey D, Pageaux GP, et al. Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen): the multinational case–population SALT study. Drug Saf 2013;36:135-44
  • Woolf CJ. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 2004;140:441-51
  • Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell 2009;139:267-84
  • Dawes JM, McMahon SB. Chemokines as peripheral pain mediators. Neurosci Lett 2013;557:1-8
  • Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 2007;10:1361-8
  • Dieppe PA, Lohmander LS. Pathogenesis and management of pain in osteoarthritis. Lancet 2005;365:965-73
  • Arendt-Nielsen L, Nie H, Laursen MB, et al. Sensitization in patients with painful knee osteoarthritis. Pain 2010;149:573-81
  • Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain 2011;152(3 Suppl):S2-15
  • Voscopoulos C, Lema M. When does acute pain become chronic? Br J Anaesth 2010;105(Suppl 1):i69-85
  • Burian M, Geisslinger G. COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites. Pharmacol Ther 2005;107:139-54
  • Rainsford KD. Current status of the therapeutic uses and actions of the preferential cyclo-oxygenase-2 NSAID, nimesulide. Inflammopharmacology 2006;14:120-37
  • Conaghan PG. A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Rheumatol Int 2012;32:1491-502
  • Bennett A, Tavares IA. COX-2 inhibitors compared and contrasted. Expert Opin Pharmacother 2001;2:1859-76
  • Sandrini G, Proietti Cecchini A, Alfonsi E, et al. Effectiveness of nimesulide in pain. A neurophysiological study in humans. Drugs Today 2001;37:21-9
  • Bianchi M, Broggini M. Anti-hyperalgesic effects of nimesulide: studies in rats and humans. Int J Clin Pract Suppl 2002;128:11-19
  • Kress HG, Ahlbeck K, Aldington D, et al. Managing chronic pain in elderly patients requires a CHANGE of approach. Curr Med Res Opin 2014;30:1153-64
  • Marengoni A, Angleman S, Melis R, et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev 2011;10:430-9
  • Giamberardino MA, Affaitati G, Fabrizio A, Costantini R. Myofascial pain syndromes and their evaluation. Best Pract Res Clin Rheumatol 2011;25:185-98
  • Giamberardino MA, Costantini R, Affaitati G, et al. Viscero-visceral hyperalgesia: characterization in different clinical models. Pain 2010;151:307-22
  • Stovner LJ, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007;27:193-210
  • Jamieson DJ, Steege JF. The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol 1996;87:55-8
  • Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol 2008;7:354-61
  • Chai NC, Rosenberg JD, Peterlin BL. The epidemiology and comorbidities of migraine and tension-type headache. Tech Reg Anesth Pain Manag 2112;16:4-13
  • Ottonello L, Dapino P, Pastorino G, et al. Nimesulide as a downregulator of the activity of the neutrophil myeloperoxidase pathway. Focus on the histoprotective potential of the drug during inflammatory processes. Drugs 1993;46(Suppl 1):29-33
  • Rossoni G, Berti F, Buschi A, et al. New data concerning the antianaphylactic and antihistaminic activity of nimesulide. Drugs 1993;46(Suppl 1):22-8
  • Pelletier JP, Martel-Pelletier J. Effects of nimesulide and naproxen on the degradation and metalloprotease synthesis of human osteoarthritic cartilage. Drugs 1993;46(Suppl 1):34-9
  • Dapino P, Ottonello L, Dallegri F. The anti-inflammatory drug nimesulide inhibits neutrophil adherence to and migration across monolayers of cytokine-activated endothelial cells. Respiration 1994;61:336-41
  • Bevilacqua M, Vago T, Baldi G, et al. Nimesulide decreases superoxide production by inhibiting phosphodiesterase type IV. Eur J Pharmacol 1994;268:415-23
  • Pelletier JP, Mineau F, Fernandes J, et al. Two NSAIDs, nimesulide and naproxen, can reduce the synthesis of urokinase and IL-6 while increasing PAI-1, in human OA synovial fibroblasts. Clin Exp Rheumatol 1997;15:393-8
  • Pelletier JP, Di Battista JA, Zhang M, et al. Effect of nimesulide on glucocorticoid receptor activity in human synovial fibroblasts. Rheumatology 1999;38(Suppl 1):11-13
  • Henrotin YE, Labasse AH, Simonis PE, et al. Effects of nimesulide and sodium diclofenac on interleukin-6, interleukin-8, proteoglycans and prostaglandin E2 production by human articular chondrocytes in vitro. Clin Exp Rheumatol 1999;17:151-60
  • Zheng SX, Mouithys-Mickalad A, Deby-Dupont GP, et al. In vitro study of the antioxidant properties of nimesulide and 4-OH nimesulide: effects on HRP- and luminol-dependent chemiluminescence produced by human chondrocytes. Osteoarthritis Cartilage 2000;8:419-25
  • Fahmi H, He Y, Zhang M, et al. Nimesulide reduces interleukin-1beta-induced cyclooxygenase-2 gene expression in human synovial fibroblasts. Osteoarthritis Cartilage 2001;9:332-40
  • Kullich W, Fagerer N, Schwann H. Effect of the NSAID nimesulide on the radical scavenger glutathione S-transferase in patients with osteoarthritis of the knee. Curr Med Res Opin 2007;23:1981-6
  • Bianchi M, Broggini M, Balzarini P, et al. Effects of nimesulide on pain and on synovial fluid concentrations of substance P, interleukin-6 and interleukin-8 in patients with knee osteoarthritis: comparison with celecoxib. Int J Clin Pract 2007;61:1270-7
  • Vellani V, Franchi S, Prandini M, et al. Nimesulide inhibits protein kinase C epsilon and substance P in sensory neurons - comparison with paracetamol. J Pain Res 2011;4:177-87
  • Vellani V, Franchi S, Prandini M, et al. Effects of NSAIDs and paracetamol (acetaminophen) on protein kinase C epsilon translocation and on substance P synthesis and release in cultured sensory neurons. J Pain Res 2013;6:111-20
  • Bernareggi A. Clinical pharmacokinetics of nimesulide. Clin Pharmacokinet 1998;35:247-74
  • Bianchi M, Ferrario P, Balzarini P, et al. Plasma and synovial fluid concentrations of nimesulide and its main metabolite after a single or repeated oral administration in patients with knee osteoarthritis. J Int Med Res 2006;34:348-54
  • Davis R, Brogden RN. Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1994;48:431-54
  • Bianchi M, Ehrlich GE, Facchinetti F, et al. Clinical applications of nimesulide in pain, arthritic conditions and fever. In: Rainsford KD (editor). Nimesulide. Actions and Uses. Basel: Birkhäuser, 2005:245-313
  • Hersh EV, Levin LM, Cooper SA, et al. Ibuprofen liquigel in oral surgery pain. Clin Ther 2000;22:1306-18
  • Zuniga JR, Noveck RJ, Schmidt WK, et al. Onset of action of diclofenac potassium liquid-filled capsules in dental surgery patients. Curr Med Res Opin 2011;27:1733-9
  • Binning A. Nimesulide in the treatment of postoperative pain: a double-blind, comparative study in patients undergoing arthroscopic knee surgery. Clin J Pain 2007;23:565-70
  • Bianchi M, Broggini M. A randomised, double-blind, clinical trial comparing the efficacy of nimesulide, celecoxib and rofecoxib in osteoarthritis of the knee. Drugs 2003;63(Suppl 1):37-46
  • Pohjolainen T, Jekunen A, Autio L, Vuorela H. Treatment of acute low back pain with the COX-2-selective anti-inflammatory drug nimesulide: results of a randomized, double-blind comparative trial versus ibuprofen. Spine 2000;25:1579-85
  • Wober W, Rahlfs VW, Büchl N, et al. Comparative efficacy and safety of the non-steroidal anti-inflammatory drugs nimesulide and diclofenac in patients with acute subdeltoid bursitis and bicipital tendinitis. Int J Clin Pract 1998;52:169-75
  • Klumb EM, Pinheiro GRC, Ferrari A, Albuquerque EMN. The treatment of acute gout arthritis. Double-blind randomized comparative study between nimesulide and indomethacin. Revista Brasileira de Medicina 1996;53:540-6
  • Barskova VG, Iakunina IA, Nasonova VA. Nimesil treatment of gouty arthritis. Ter Arkh 2003;75:60-4
  • Barskova VG, Nasonova VA, Tsapina TN, et al. The effectiveness and safety of nimesulide (nimesile) in patients with gouty arthritis. Klin Med (Mosk) 2004;82:49-54
  • Kudaeva FM, Eliseev MS, Barskova VG, Nasonova VA. Comparison of the time to analgetic and anti-inflammatory effect in the treatment of gouty arthritis with nimesulide and sodium diclofenac. Ter Arkh 2007;79:35-40
  • Valanne J, Korttila K, Ylikorkala O. Intravenous diclofenac sodium decreases prostaglandin synthesis and postoperative symptoms after general anaesthesia in outpatients undergoing dental surgery. Acta Anaesthesiol Scand 1987;31:722-7
  • Cornaro G. A new non steroidal anti-inflammatory drug in the treatment of inflammation due to parodental surgery. Curr Ther Res 1983;33:982-9
  • Salvato A, Zambruno E, Ventrini E, Savio G. Sperimentazione clinica di un nuovo antiedemigeno orale: nimesulide. Giorn Stomat Ortognat 1984;3:184-91
  • Ragot JP, Monti T, Macciocchi A. Controlled clinical investigation of acute analgesic activity of nimesulide in pain after oral surgery. Drugs 1993;46(Suppl 1):162-7
  • Ragot JP, Giorgi M, Marinoni M, et al. Acute activity of nimesulide in the treatment of pain after oral surgery – double blind, placebo and mefenamic acid controlled study. Eur J Clin Res 1994;5:39-50
  • Levrini L, Carraro M, Rizzo S, et al. Prescriptions of NSAIDs to patients undergoing third molar surgery – an observational, prospective, multicentre survey. Clin Drug Invest 2008;28:657-68
  • Pulkkinen MO. Is there a rationale for the use of nimesulide in the treatment of dysmenorrhea? Drugs Today 2001;37:31-8
  • Facchinetti F, Piccinini F, Sgarbi L, et al. Nimesulide in the treatment of primary dysmenorrhoea: a double-blind study versus diclofenac. Drugs Today 2001;37:39-45
  • Brandes JL, Freitag FG, Zacur HA. Understanding and diagnosing menstrually related migraine. Adv Stud Med 2005;5:S774-82
  • Silberstein SD, Stirpe JC. COX inhibitors for the treatment of migraine. Expert Opin Pharmacother 2014;15:1863-74
  • Giacovazzo M, Gallo MF, Guidi V, et al. Nimesulide in the treatment of menstrual migraine. Drugs 1993;46(Suppl 1):140-1
  • Affaitati G, Fabrizio A, Lopopolo M, et al. Use of NSAIDs for migraine attacks: results from a retrospective analysis in an Italian Headache Center. 15th World Congress of Pain 2014, Abs PT293
  • Motola D, Vaccheri A, Silvani MC, et al. Pattern of NSAID use in the Italian general population: a questionnaire-based survey. Eur J Clin Pharmacol 2004;60:731-8
  • Ferrari A, Pasciullo G, Savino G, et al. Headache treatment before and after the consultation of a specialized centre: a pharmacoepidemiology study. Cephalalgia 2004;24:356-62
  • Davidson DG, Eastham WN. Acute liver necrosis following overdose of paracetamol. Br Med J 1966;2:497-9
  • Mitchell JR, Jollow DJ, Potter WZ, et al. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther 1973;187:185-94
  • Schapira D, Bassan L, Nahir AM, Scharf Y. Diclofenac-induced hepatotoxicity. Postgrad Med J 1986;62:63-5
  • Banks AT, Zimmerman HJ, Ishak KG, Harter JG. Diclofenac-associated hepatotoxicity: analysis of 180 cases reported to the Food and Drug Administration as adverse reactions. Hepatology 1995;22:820-7
  • Walker AM. Quantitative studies of the risk of serious hepatic injury in persons using nonsteroidal anti-inflammatory drugs. Arthritis Rheum 1997;40:201-8
  • Traversa G, Bianchi C, Da Cas R, et al. Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs. BMJ 2003;327:18-22
  • Farkouh ME, Greenberg BP. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs. Am J Cardiol 2009;103:1227-37
  • Suleyman H, Cadirci E, Albayrak A, Halici Z. Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal anti-inflammatory drug. Curr Med Chem 2008;15:278-83
  • Fanelli A, Romualdi P, Vigano R, et al. Non-selective non-steroidal anti-inflammatory drugs (NSAIDs) and cardiovascular risk. Acta Biomed 2013;84:1-7
  • Franchi S, Heiman F, Visentin E, Sacerdote P. Survey on appropriateness of use of nimesulide in nine European countries. Drug Healthc Patient Saf 2015;7:51-5
  • Mattia C, Ciarcia S, Muhindo A, Coluzzi F. Nimesulide 25 anni dopo. Minerva Med 2010;101:285-93

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.